AstraZeneca India gets CDSCO nod for its chemotherapy drug additional indications
- Posted on September 24, 2024
- By Financial Express
- 3 Views
AstraZeneca India gets CDSCO nod for its chemotherapy drug additional indications
AstraZeneca Pharma India Ltd has received permission to import and distribute Durvalumab for the treatment of resectable non-small cell lung cancer (NSCLC) in India. The approval is subject to statutory approvals and the company’s focus on exploring new treatment combinations to improve outcomes for patients.
